Alpine Creek and BioCorRx Announce Major Investment Into BioCorRx
Alpine Creek Capital Partners ("Alpine Creek") and BioCorRx, Inc. (OTC:BICX) ("BioCorRx" or "the Company"), are pleased to announce an investment by Alpine Creek in the Company. The Company specializes in solutions for alcohol and opioid addiction treatment using its proprietary, non-addictive medication-assisted treatment (MAT) program called the BioCorRx® Recovery Program. The Company has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of an FDA-approved medicine, naltrexone. After being surgically implanted by a...
View full press release